Position 5-7: Finalization

Mouth and Pharynx

Select the specific approach and device combination to identify the exact billable procedure code.

Approach X

External

Device 3

XW0DX38 Introduction Mouth and Pharynx to New Technology Group 8 with Maribavir Anti-infective, External Approach

Device 8

XW0DX82 Introduction Mouth and Pharynx to New Technology Group 2 with Uridine Triacetate, External Approach

Device F

XW0DXF5 Introduction Mouth and Pharynx to New Technology Group 5 with Other New Technology Therapeutic Substance, External Approach

Device J

XW0DXJ9 Introduction Mouth and Pharynx to New Technology Group 9 with Quizartinib Antineoplastic, External Approach

Device K

XW0DXK8 Introduction Mouth and Pharynx to New Technology Group 8 with Sabizabulin, External Approach

Device M

XW0DXM6 Introduction Mouth and Pharynx to New Technology Group 6 with Baricitinib, External Approach

Device N

XW0DXN9 Introduction Mouth and Pharynx to New Technology Group 9 with SER-109, External Approach

Device R

XW0DXR7 Introduction Mouth and Pharynx to New Technology Group 7 with Fostamatinib, External Approach

Device V

XW0DXVB Introduction Mouth and Pharynx to New Technology Group 11 with Xanomeline and Trospium Chloride, External Approach